Manchester Capital Management’s Mesa Laboratories MLAB Stock Holding History

Manchester Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-663	Closed	-$72.8K	–	1166
2024 Q1	$72.8K	Hold	663	–	–	0.01%	433
2023 Q4	$69.5K	Hold	663	–	–	0.01%	388
2023 Q3	$69.7K	Hold	663	–	–	0.01%	383
2023 Q2	$85.2K	Sell	663 -21	-3%	-$3.2K	0.01%	366
2023 Q1	$120K	Buy	684 +1	+0.1%	+$179	0.02%	344
2022 Q4	$114K	Buy	683 +3	+0.4%	+$470	0.02%	305
2022 Q3	$96K	Sell	680 -7	-1%	-$1.28K	0.02%	293
2022 Q2	$140K	Buy	687 +24	+4%	+$5.25K	0.02%	249
2022 Q1	$169K	Hold	663	–	–	0.02%	267
2021 Q4	$218K	Hold	663	–	–	0.03%	257
2021 Q3	$200K	Hold	663	–	–	0.03%	279
2021 Q2	$180K	Sell	663 -405	-38%	-$103K	0.02%	270
2021 Q1	$260K	Hold	1,068	–	–	0.04%	236
2020 Q4	$306K	Sell	1,068 -735	-41%	-$202K	0.05%	200
2020 Q3	$459K	Hold	1,803	–	–	0.07%	148
2020 Q2	$391K	Hold	1,803	–	–	0.05%	169
2020 Q1	$408K	Hold	1,803	–	–	0.07%	154
2019 Q4	$450K	Hold	1,803	–	–	0.05%	174
2019 Q3	$429K	Hold	1,803	–	–	0.05%	168
2019 Q2	$441K	Sell	1,803 -197	-10%	-$45.9K	0.06%	162
2019 Q1	$461K	Hold	2,000	–	–	0.06%	151
2018 Q4	$422K	Hold	2,000	–	–	0.06%	151
2018 Q3	$371K	Hold	2,000	–	–	0.05%	165
2018 Q2	$422K	Hold	2,000	–	–	0.06%	153
2018 Q1	$297K	Hold	2,000	–	–	0.05%	169
2017 Q4	$249K	Hold	2,000	–	–	0.04%	177
2017 Q3	$299K	Hold	2,000	–	–	0.05%	149
2017 Q2	$287K	Hold	2,000	–	–	0.05%	160
2017 Q1	$245K	Hold	2,000	–	–	0.04%	167
2016 Q4	$246K	Hold	2,000	–	–	0.04%	160
2016 Q3	$229K	Hold	2,000	–	–	0.03%	175
2016 Q2	$246K	Hold	2,000	–	–	0.04%	172
2016 Q1	$193K	Hold	2,000	–	–	0.03%	201
2015 Q4	$199K	Hold	2,000	–	–	0.03%	213
2015 Q3	$223K	Hold	2,000	–	–	0.04%	184
2015 Q2	$178K	Buy	+2,000	New	+$169K	0.03%	221

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manchester Capital Management's MLAB Position: Q2 2024 in Review

Manchester Capital Management sold out of Mesa Laboratories (MLAB) in Q2 2024, closing a stake of 663 shares — an estimated $72.8K sold.

Manchester Capital Management first reported a position in MLAB in Q2 2015 and held it in 36 quarters. The position peaked at $461K in Q1 2019. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2024.

Manchester Capital Management reported no remaining Mesa Laboratories position as of Q2 2024 after selling out during the quarter.
Manchester Capital Management sold 663 Mesa Laboratories shares in Q2 2024, an estimated $72.8K.
Manchester Capital Management first reported a position in Mesa Laboratories in Q2 2015 and held it in 36 quarters.
Manchester Capital Management's Mesa Laboratories position peaked at $461K in Q1 2019.
154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2024.

Based on Manchester Capital Management's 13F filing for Q2 2024, filed 8 Aug 2024.